| High-sensitivity C-Reactive Protein (hs-CRP) |
Important for the diagnosis and treatment monitoring of inflammation,
tissue injury, malignant tumors, and other diseases.
|
| Malignant Tumor Specific Growth Factor |
A broad-spectrum tumor marker used for auxiliary diagnosis of tumors
and follow-up observation of high-risk populations.
|
| Antistreptolysin O (ASO) |
Commonly used as one of the laboratory tests for rheumatic diseases;
provides clues and evidence for doctors to diagnose rheumatic conditions.
|
| Squamous Cell Carcinoma Antigen (SCC) |
A marker for squamous cell carcinoma, used for auxiliary diagnosis
and treatment monitoring of squamous cell cancers. It has relatively
high specificity; significantly elevated levels should raise suspicion
for squamous cell carcinoma.
|
| Neuron-specific Enolase (NSE) |
Detects neuron-specific enolase, one of the tumor markers.
It is recommended to combine with other tumor markers when used.
|
| Carbohydrate Antigen 72-4 (CA72-4) |
Detects CA72-4, which can serve as one of the tumor markers for
gastrointestinal tumors. It is recommended to combine with other
tumor markers when used.
|
| Glycated Hemoglobin (HbA1c) |
Reflects the average blood glucose level in the 1–2 months prior
to the examination; it is a key screening indicator for diabetes.
|
| Homocysteine (Hcy) |
A marker of cardiovascular disease risk; can be used as a risk
assessment factor to indicate the danger of disease occurrence.
|
| Cytokeratin 19 Fragment (CYFRA21-1) |
An important indicator for the differential diagnosis, treatment
monitoring, and prognosis judgment of non-small cell lung cancer
(NSCLC).
|
| Lipoprotein(a) |
Elevated Lipoprotein(a) is an independent risk indicator for
atherosclerosis.
|
| Thyroid Function Test (3 items) |
Helps in the diagnosis of thyroid diseases or thyroid dysfunction;
it is currently the most commonly used endocrine test.
|
| Hepatitis B Two Half (HBsAg/Ab, HBeAg/Ab, HBcAb) |
Used to detect acute hepatitis B, chronic persistent hepatitis B,
chronic active hepatitis B, HBsAg carriers, and whether antibodies
appear after hepatitis B vaccination.
|
| Lactate Dehydrogenase (LDH) |
Increased LDH activity is mainly seen in myocardial infarction,
acute or chronic hepatitis, liver cancer, skeletal muscle diseases,
blood system diseases, pulmonary infarction, hypothyroidism,
kidney syndrome, and advanced malignant tumors.
|
| α-Hydroxybutyrate Dehydrogenase (α-HBDH) |
Elevated levels can be seen in myocardial infarction, active
rheumatic carditis, acute viral myocarditis, hemolytic anemia, etc.
|
| Creatine Kinase (CK) |
Elevated creatine kinase can be seen in myocardial infarction,
viral myocarditis, pericarditis, dermatomyositis, muscular dystrophy,
cerebral infarction, etc.
|
| Carbohydrate Antigen 50 (CA50) |
Detects CA50, one of the tumor markers. It is recommended to combine
with other tumor markers when used.
|
| Carbohydrate Antigen 242 (CA242) |
Detects CA242, one of the tumor markers. It is recommended to combine
with other tumor markers when used.
|
| Carbohydrate Antigen 19-9 (CA19-9) |
Detects CA19-9, one of the tumor markers for gastrointestinal tumors.
It is recommended to combine with other tumor markers when used.
|
| Free Prostate-Specific Antigen (fPSA) |
An auxiliary marker for prostate cancer screening. |
| Total Prostate-Specific Antigen (tPSA) |
A specific marker for screening prostate tumors. However, it can
also be mildly elevated in benign prostatic hyperplasia and prostatitis.
|
| Serum Triglycerides |
Serum triglycerides — one of the most common blood lipid tests.
|
| Serum Total Cholesterol |
Combined with other blood lipid tests to understand lipid metabolism.
|
| Routine Blood Test (5-classification) |
One of the most commonly used initial screening tests in clinical
practice; provides clues and evidence for doctors to diagnose
blood system diseases.
|
| Helicobacter pylori Antibody (Blood) |
Detects Helicobacter pylori antibodies. |
| Renal Function Test (3 items) |
Checks for kidney function impairment, such as uremia and gouty
kidney disease.
|
| Routine Urinalysis 1 |
Can indicate urinary system diseases: acute or chronic nephritis,
pyelonephritis, cystitis, urethritis, nephrotic syndrome, lupus
nephritis, hemoglobinuria, renal infarction, heavy metal salt or
drug-induced acute renal tubular necrosis, kidney or bladder tumors, etc.
|
| Fasting Blood Glucose |
Blood glucose (blood sugar) refers to the glucose in the blood.
It is of great value in assessing the body's glucose metabolism
status, diagnosing glucose metabolism disorders, and guiding
clinicians in formulating and adjusting treatment plans.
|
| Alpha-Fetoprotein (AFP) Quantitative |
Can indicate primary liver cancer, germ cell tumors, liver cirrhosis, etc.
|
| Carcinoembryonic Antigen (CEA) Quantitative |
A broad-spectrum tumor marker that can indicate rectal cancer,
colon cancer, lung cancer, breast cancer, pancreatic cancer, etc.
|
| Serum High-Density Lipoprotein Cholesterol (HDL-C) |
Detects serum high-density lipoprotein. One of the common blood lipid
tests. It has a protective effect on blood vessels. Low levels
increase the risk of atherosclerosis.
|
| Serum Low-Density Lipoprotein Cholesterol (LDL-C) |
Detects serum low-density lipoprotein. One of the common blood lipid
tests. Elevated LDL is a high-risk factor for coronary heart disease,
myocardial infarction, cerebrovascular disease, and atherosclerosis.
|
| Rheumatoid Factor (RF) |
A laboratory test for rheumatic diseases; provides clues and
evidence for doctors to diagnose rheumatic conditions.
|
| Liver Function Test (11 items) |
Can indicate hepatobiliary system diseases: acute infectious hepatitis,
toxic hepatitis, fatty liver, cholangitis, cholecystitis,
drug-induced toxic hepatitis, alcoholic hepatitis, and jaundice.
|
